Follow
Thomas S Harrison
Thomas S Harrison
Verified email at sgul.ac.uk
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
52212021
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America
JR Perfect, WE Dismukes, F Dromer, DL Goldman, JR Graybill, RJ Hamill, ...
Clinical infectious diseases 50 (3), 291-322, 2010
30382010
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
18242020
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1815*2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13082021
Cryptococcal meningitis
T Bicanic, TS Harrison
British medical bulletin 72 (1), 99-118, 2004
6382004
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer, A Rajanuwong, W Chierakul, GE Griffin, RA Larsen, ...
The Lancet 363 (9423), 1764-1767, 2004
5912004
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis
A Jindani, TS Harrison, AJ Nunn, PPJ Phillips, GJ Churchyard, ...
New England Journal of Medicine 371 (17), 1599-1608, 2014
4892014
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
475*2021
Fungal infections in HIV/AIDS
AH Limper, A Adenis, T Le, TS Harrison
The Lancet Infectious Diseases 17 (11), e334-e343, 2017
4522017
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy
PR Williamson, JN Jarvis, AA Panackal, MC Fisher, SF Molloy, A Loyse, ...
Nature Reviews Neurology 13 (1), 13-24, 2017
4502017
Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa
JN Jarvis, SD Lawn, M Vogt, N Bangani, R Wood, TS Harrison
Clinical infectious diseases 48 (7), 856-862, 2009
3752009
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
JN Jarvis, T Bicanic, A Loyse, D Namarika, A Jackson, JC Nussbaum, ...
Clinical infectious diseases 58 (5), 736-745, 2014
3742014
Tackling the emerging threat of antifungal resistance to human health
MC Fisher, A Alastruey-Izquierdo, J Berman, T Bicanic, EM Bignell, ...
Nature reviews microbiology 20 (9), 557-571, 2022
3662022
Antifungal combinations for treatment of cryptococcal meningitis in Africa
SF Molloy, C Kanyama, RS Heyderman, A Loyse, C Kouanfack, ...
New England Journal of Medicine 378 (11), 1004-1017, 2018
3652018
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis
JN Jarvis, A Percival, S Bauman, J Pelfrey, G Meintjes, GN Williams, ...
Clinical infectious diseases 53 (10), 1019-1023, 2011
3592011
HIV-associated cryptococcal meningitis
JN Jarvis, TS Harrison
Aids 21 (16), 2119-2129, 2007
3372007
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or …
T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison
Clinical infectious diseases 45 (1), 76-80, 2007
3372007
Superoxide Dismutase Influences the Virulence of Cryptococcus neoformans by Affecting Growth within Macrophages
GM Cox, TS Harrison, HC McDade, CP Taborda, G Heinrich, ...
Infection and immunity 71 (1), 173-180, 2003
3312003
Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
JN Jarvis, G Meintjes, A Williams, Y Brown, T Crede, TS Harrison
BMC infectious diseases 10, 1-6, 2010
3082010
The system can't perform the operation now. Try again later.
Articles 1–20